Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Diken

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Macromolecular Rapid Communications|April 15, 2016
Reductive Decationizable Block Copolymers for Stimuli-Responsive mRNA DeliveryLutz Nuhn, Leonard Kaps, Mustafa Diken, et al.
Current Opinion in Immunology|December 31, 2015
Mutanome directed cancer immunotherapyMathias Vormehr, Mustafa Diken, Sebastian Boegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Targeting the Heterogeneity of Cancer with Individualized Neoepitope VaccinesÖzlem Türeci, Mathias Vormehr, Mustafa Diken, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
FLT3 Ligand as a Molecular Adjuvant for Naked RNA VaccinesSebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Nature Cancer|July 6, 2023
The landscape of T cell antigens for cancer immunotherapyAviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the MutanomeMustafa Diken, Mathias Vormehr, Christian Grunwitz, et al.
Cancer Immunology, Immunotherapy : CII|September 23, 2009
CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, GermanyMustafa Diken, Melanie Widenmeyer, Cécile Gouttefangeas, et al.
RNA Biology|February 4, 2011
Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeuticsAndreas N Kuhn, Mustafa Diken, Sebastian Kreiter, et al.
Nanomedicine (London, England)|October 5, 2016
Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanomaStephan Grabbe, Heinrich Haas, Mustafa Diken, et al.
Journal of Immunology Research|March 29, 2016
RNA Vaccination Therapy: Advances in an Emerging FieldSebastian Kreiter, Mustafa Diken, Steve Pascolo, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Macromolecular Rapid Communications|April 15, 2016
Reductive Decationizable Block Copolymers for Stimuli-Responsive mRNA DeliveryLutz Nuhn, Leonard Kaps, Mustafa Diken, et al.
Current Opinion in Immunology|December 31, 2015
Mutanome directed cancer immunotherapyMathias Vormehr, Mustafa Diken, Sebastian Boegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Targeting the Heterogeneity of Cancer with Individualized Neoepitope VaccinesÖzlem Türeci, Mathias Vormehr, Mustafa Diken, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
FLT3 Ligand as a Molecular Adjuvant for Naked RNA VaccinesSebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Nature Cancer|July 6, 2023
The landscape of T cell antigens for cancer immunotherapyAviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the MutanomeMustafa Diken, Mathias Vormehr, Christian Grunwitz, et al.
Cancer Immunology, Immunotherapy : CII|September 23, 2009
CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, GermanyMustafa Diken, Melanie Widenmeyer, Cécile Gouttefangeas, et al.
RNA Biology|February 4, 2011
Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeuticsAndreas N Kuhn, Mustafa Diken, Sebastian Kreiter, et al.
Nanomedicine (London, England)|October 5, 2016
Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanomaStephan Grabbe, Heinrich Haas, Mustafa Diken, et al.
Journal of Immunology Research|March 29, 2016
RNA Vaccination Therapy: Advances in an Emerging FieldSebastian Kreiter, Mustafa Diken, Steve Pascolo, et al.
Pageof 10